Removing Barriers to Colorectal Cancer Screening Act of 2017

Bill: 115-hr-1017
Sponsor: full_name: Rep. Dent, Charles W. [R-PA-15]
Introduced: 2017-02-13
Policy area: Health
Subjects: Cancer

Digestive and metabolic diseases

Medical tests and diagnostic methods

Medicare
Latest action: action_date: 2018-05-15
text: ASSUMING FIRST SPONSORSHIP - Mr. Lance asked unanimous consent that he may hereafter be considered as the first sponsor of H.R. 1017, a bill originally introduced by Representative Dent of Pennsylvania, for the purpose of adding cosponsors and requesting reprintings under clause 7 of rule XII. Agreed to without objection.

Summaries:
action_date: 2017-02-13
action_desc: Introduced in House
text: <p><b>Removing Barriers to Colorectal Cancer Screening Act of 2017</b></p> <p>This bill waives Medicare&nbsp;coinsurance requirements with respect to colorectal cancer screening tests, regardless of the code billed for a resulting diagnosis or procedure.</p>

tv_txt: I 115th CONGRESS 1st Session H. R. 1017 IN THE HOUSE OF REPRESENTATIVES February 13, 2017 Mr. Dent (for himself, Mr. Payne , and Mr. Lance ) introduced the following bill; which was referred to the Committee on Energy and Commerce , and in addition to the Committee on Ways and Means , for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned A BILL To amend title XVIII of the Social Security Act to waive coinsurance under Medicare for colorectal cancer screening tests, regardless of whether therapeutic intervention is required during the screening.

1. Short title This Act may be cited as the Removing Barriers to Colorectal Cancer Screening Act of 2017 . 2. Findings Congress finds the following: (1) Colorectal cancer is the second leading cause of cancer death among men and women combined in the United States. (2) In 2017, more than 135,000 Americans will be diagnosed with colorectal cancer and approximately 50,000 Americans will die from it. (3) Approximately 60 percent of colorectal cancer cases and 70 percent of deaths occur in those aged 65 and older. (4) Colorectal cancer screening colonoscopy allows for the detection and removal of polyps, or abnormal growths, that could become cancerous, as well as for the early detection of colorectal cancer when treatment can be most effective. (5) Although colorectal cancer is largely preventable, one in three adults between the ages of 50 and 75 are not up to date with recommended colorectal cancer screening. (6) Over 1,000 organizations have committed to eliminating colorectal cancer as a major public health problem and are working toward the shared goal of reaching 80 percent screened for colorectal cancer by 2018. (7) Colorectal cancer screening colonoscopy is a highly effective preventive service, and removing financial barriers can help to increase screening rates. 3. Waiving medicare coinsurance for co­lo­rec­tal cancer screening tests (a) In general Section 1833(a)(1)(Y) of the Social Security Act ( 42 U.S.C. 1395l(a)(1)(Y) ) is amended by inserting , including a colorectal cancer screening test (regardless of the code that is billed for the establishment of a diagnosis as a result of the test, or for the removal of tissue or other procedure that is furnished in connection with, as a result of, and in the same clinical encounter as the screening test), after section 1861(ddd)(3) . (b) Effective date The amendment made by this section shall apply to items and services furnished after the date of the enactment of this Act.